What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Acetylation Group: Role in Proteins and Drugs

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-09-19

An acetyl group is a two-carbon acyl unit with the formula CH3CO- that is transferred enzymatically from the donor molecule acetyl-CoA onto a target atom, most often the epsilon-amino nitrogen of a lysine side chain. Acetylation is the reversible addition of that group, and deacetylation is its removal, so the acetyl group acts as a small, charge-neutralizing switch that cells use to control protein function, chromatin state, and the fate of certain drugs.

The acetyl group matters because it sits at the intersection of metabolism, gene regulation, and pharmacology. Acetyl-CoA is the same molecule that feeds the citric acid cycle, so the availability of acetyl groups links what a cell eats to which genes it reads. On the protein side, lysine acetylation is a ubiquitous post-translational modification governed by two opposing enzyme families, lysine acetyltransferases (KATs, also called HATs) that add the group and lysine deacetylases (KDACs, also called HDACs) that remove it [1]. On the drug side, the same chemistry acetylates aspirin, isoniazid, and many other compounds, changing their activity and clearance. This article covers the chemistry of the acetyl group, its transfer from acetyl-CoA, histone and non-histone acetylation, the writer-eraser-reader framework, and clinically relevant examples of drug acetylation.

What the Acetyl Group Actually Is

The acetyl group is CH3CO-. It consists of a methyl carbon bonded to a carbonyl carbon, and the carbonyl carbon is the electrophilic center that accepts a nucleophile. When the group is written as CH3CO-, the trailing dash marks the bond that will form to the target atom. In the free acid form, CH3COOH is acetic acid, the two-carbon carboxylic acid that gives vinegar its bite. When the group is attached to a protein, it is no longer an acid. It is an amide, because the carbonyl carbon bonds to a nitrogen.

The target atom in protein acetylation is almost always nitrogen. On lysine, the side chain ends in an amino group, and the epsilon nitrogen is the nucleophile that attacks the acetyl donor. The product is N-epsilon-acetyllysine. This single chemical change removes a positive charge from the side chain at physiological pH, because the unmodified lysine ammonium group is protonated and the amide is neutral. That loss of positive charge is the whole functional point. It weakens ionic contacts between the lysine and negatively charged partners such as DNA phosphate backbones or acidic patches on other proteins.

Two other acetylated positions are worth naming. The alpha-amino group at the very N-terminus of a protein can be acetylated, a modification called N-terminal acetylation that is usually co-translational and largely irreversible. Serine and threonine hydroxyls can also accept acetyl groups in some contexts, forming O-acetyl esters, but lysine N-acetylation is the dominant and best studied form.

The Donor Molecule Acetyl-CoA

Acetyl-CoA is the universal acetyl donor. It is a thioester in which the acetyl group is attached to the sulfur of coenzyme A. Thioesters are high-energy bonds, so acetyl-CoA carries a transfer potential that lets acetyltransferases move the group onto a substrate without needing ATP for each individual transfer. The electrophilic carbonyl carbon of the thioester is attacked by the lysine nitrogen, coenzyme A leaves as a thiol, and the amide bond forms.

Acetyl-CoA sits at a metabolic crossroads. It is produced from pyruvate by pyruvate dehydrogenase, from fatty acid beta-oxidation, and from acetate by acetyl-CoA synthetase. Because one pool supplies both energy metabolism and protein acetylation, the acetyl group is a direct sensor of cellular metabolic state. When acetyl-CoA is abundant, acetyltransferase reactions are favored. When it is scarce, deacetylation dominates. This coupling is why protein acetylation is described as a link between metabolism and gene expression, and it is a recurring theme in cardiovascular pathology and metabolic disease [2].

Histone Acetylation and Gene Activation

Histones are small, highly basic proteins that package DNA into nucleosomes. Each nucleosome contains an octamer of two copies each of H2A, H2B, H3, and H4, wrapped by about 147 base pairs of DNA. The histone tails extend outward from the octamer and carry most of the regulatory modifications. These tails are rich in lysine and arginine, which gives them a strong positive charge that binds the negatively charged DNA backbone.

Why Acetylation Opens Chromatin

When a lysine in a histone tail is acetylated, its positive charge is neutralized. The electrostatic grip between the histone tail and DNA loosens, and the chromatin fiber becomes less compact. Loosened chromatin is more accessible to transcription factors, RNA polymerase, and the machinery that initiates transcription. For this reason, histone lysine acetylation is generally an activating mark. It is associated with open, transcriptionally permissive chromatin, and its removal by deacetylases is generally repressive.

The evidence for this activating role is broad and comes from many systems. In T2-high asthma, ChIP-seq profiling of peripheral blood mononuclear cells found that nearly all differentially enriched H3K9ac regions mapped to promoters, and most showed acetylation loss in patients, with the affected genes clustered in T cell receptor signaling and T helper differentiation pathways [3]. In cotton, silencing the histone acetyltransferase GhHAT11 reduced plant height and lowered H3K9ac at the promoters of gibberellin biosynthetic genes, showing that a single acetyltransferase can control a hormone pathway through a specific histone mark [4]. In white birch, knocking out the histone deacetylase BpHST1 altered H3K27ac levels at the cellulase gene BpCEL1 and changed branch angle, a reminder that deacetylases shape plant architecture as well as animal gene expression [5].

H3K9ac, H3K27ac, and Other Marks

Histone acetylation is named by the histone, the residue, and the modification. H3K9ac means acetylation of lysine 9 of histone H3. H3K27ac means acetylation of lysine 27 of histone H3. H4K12ac and H4K16ac are common on histone H4. Different marks have different genomic distributions. H3K9ac and H3K27ac are enriched at active promoters and enhancers. H4K16ac is linked to a more open chromatin fiber. These marks are read by dedicated proteins, discussed below, and they are measured by chromatin immunoprecipitation followed by sequencing (ChIP-seq) or by the newer iCUT&Tag method, which was used to profile 12 fruit species from as few as 500 nuclei and identified H3K9ac as a recurrent feature of ripening-linked gene activation [6].

Deacetylation by HDACs

Histone deacetylases remove the acetyl group and restore the positive charge, which typically compacts chromatin and silences transcription. HDACs are divided into classes by structure and cofactor dependence. The classical HDACs (class I, II, and IV) are zinc-dependent enzymes. The sirtuins (class III) are NAD+-dependent, which means their activity is tied to cellular energy status.

Deacetylation is not merely the absence of acetylation. It is an active regulatory event. In mice, chronic stress before long isoflurane anesthesia was associated with reduced H3K9 and H4K12 acetylation and impaired contextual fear memory, and the effect involved an interaction between RbAp48 and HDAC2 [7]. In Drosophila, the deacetylase Hdac3 removes an acetyl group from lysine 315 of the antiapoptotic protein Diap1, stabilizing it and suppressing apoptosis, an example of a deacetylase acting on a non-histone substrate in the cytoplasm [8]. In hepatocytes, SIRT6 deacetylates H3K9 and H3K56 to repress cholesterol biosynthetic genes in response to sterol status, linking a sirtuin to feedback control of the SREBP2 pathway [9].

The Bromodomain: Reading the Acetyl Mark

Acetylation needs readers. The bromodomain is a protein module of roughly 110 amino acids that binds acetylated lysine. Bromodomains are found in many chromatin regulators, including the histone acetyltransferases p300 and CBP, the bromodomain and extra-terminal (BET) family proteins BRD2, BRD3, BRD4, and BRDT, and subunits of chromatin remodeling complexes. A bromodomain does not bind any acetylated lysine. It reads a specific acetylated sequence context, which is how the mark carries information rather than being a generic signal.

The writer-eraser-reader framework organizes this system. Writers add the mark, erasers remove it, and readers interpret it and recruit downstream machinery. The table below summarizes the main players.

Role	Protein family or example	Activity	Example mark or substrate
Writer	KATs / HATs, including p300, CBP, GCN5, MYST family	Transfer acetyl from acetyl-CoA to lysine	H3K9ac, H3K27ac, H4K16ac
Writer	GhHAT11 (plant HAT)	Acetylate histone H3 at target promoters	H3K9ac at GA biosynthetic genes [4]
Eraser	HDAC1, HDAC2, HDAC3 (zinc-dependent)	Remove acetyl group from lysine	H3K9ac, H4K12ac, Diap1 K315 [8]
Eraser	SIRT1 to SIRT7 (NAD+-dependent)	Remove acetyl group, consume NAD+	H3K9ac, H3K56ac [9]
Eraser	HDC1, HDA1, HDA19, HST1 (plant)	Deacetylate histones in complex with corepressors	H3K9ac, H3K14ac, H3K27ac [5][10]
Reader	Bromodomain proteins, including BRD4 and p300/CBP	Bind acetylated lysine and recruit transcription machinery	H3K27ac, H4K16ac
Reader	RbAp48	Accessory factor that guides HDAC complexes	H3K9ac, H4K12ac [7]

Non-Histone Acetylation

Acetylation is not limited to histones. Thousands of non-histone proteins carry acetylated lysines, and the modification changes their stability, localization, enzymatic activity, and interactions. This broader landscape is called the acetylome, and it is mapped by mass spectrometry after enrichment of acetylated peptides.

Non-histone acetylation touches nearly every major cellular process. It regulates the DNA damage response, cytoskeletal remodeling, autophagic flux, and signal transduction [1]. It also participates in fibrosis, where excessive extracellular matrix deposition follows chronic tissue injury, and where acetylation of both histones and non-histone targets contributes to the fibrotic program [1]. In the cardiovascular system, protein acylation including acetylation regulates chromatin status and metabolic signaling, and maintaining acetylation homeostasis or activating SIRT1 can reduce myocardial injury and improve cardiac remodeling in experimental models [2].

A specific example shows how precise the regulation can be. In Drosophila, the acetyl group on lysine 315 of Diap1 is removed by Hdac3, and this deacetylation stabilizes the protein. An acetylation-deficient mutant of Diap1 is more stable than the wild-type protein, which means the acetyl group on that one lysine is a destabilizing signal that must be erased for the protein to persist [8]. This is the opposite of the usual histone logic, where acetylation activates. The lesson is that the functional consequence of acetylation depends on the protein and the site, not on the chemistry alone.

Crosstalk with Methylation and Phosphorylation

Acetylation does not act alone. It crosstalks with other post-translational modifications, and the same lysine residue can sometimes carry either an acetyl group or a methyl group, so the two modifications compete directly. Phosphorylation of a nearby serine can recruit or repel the enzymes that write the acetyl mark. In yeast, loss of H4K16 acetylation disrupted the H3K79 methylation zone established by Dot1, showing that an acetylation mark on one histone can shape a methylation mark on another [11]. This trans-histone crosstalk means that reading a single mark in isolation can mislead you. The combinatorial pattern, sometimes called the histone code, determines the transcriptional outcome.

The crosstalk extends to other acyl groups. Lysine can also be modified by lactylation, 2-hydroxyisobutyrylation, succinylation, and butyrylation, all of which use acyl-CoA donors related to acetyl-CoA. These competing modifications mean that the acetyl group is one option among several, and the balance between them reflects the metabolic state of the cell [2].

Drug Acetylation

The acetyl group also modifies drugs, and this chemistry has direct clinical consequences. Drug acetylation is a phase II conjugation reaction. It usually makes a compound more water soluble and easier to excrete, but it can also activate or deactivate a drug, or create a reactive intermediate.

Isoniazid and NAT2

Isoniazid is a first-line drug for tuberculosis. It is acetylated by N-acetyltransferase 2 (NAT2), a cytosolic enzyme that transfers an acetyl group from acetyl-CoA to the drug. NAT2 activity varies between people because of common polymorphisms in the NAT2 gene, which produces the classic fast, intermediate, and slow acetylator phenotypes. Slow acetylators clear isoniazid more slowly and maintain higher plasma concentrations, which is associated with a greater risk of peripheral neuropathy and hepatotoxicity. Fast acetylators clear it more quickly. This is a textbook example of pharmacogenetics, where a single enzyme polymorphism changes drug handling. The clinical decision about isoniazid use belongs to a prescriber, and this article does not give doses or monitoring schedules.

Aspirin and Irreversible COX Acetylation

Aspirin (acetylsalicylic acid) is itself an acetylated compound, and its mechanism depends on transferring its acetyl group to a target protein. Aspirin acetylates cyclooxygenase (COX) enzymes irreversibly. The acetyl group from aspirin is transferred to a specific serine residue in the COX active site, which blocks the enzyme from converting arachidonic acid into prostaglandin precursors. Because the modification is covalent and irreversible, the enzyme cannot recover. Platelets cannot synthesize new COX protein because they lack a nucleus, so a single low dose of aspirin suppresses platelet thromboxane production for the lifespan of those platelets, roughly 7 to 10 days. This is why aspirin's antiplatelet effect lasts far longer than the drug itself remains in the blood. The irreversible acetylation of COX is one of the clearest examples of a drug acting through acetyl transfer.

Other Examples

Many other drugs and xenobiotics are acetylated. Sulfonamides, hydralazine, procainamide, and dapsone are all NAT2 substrates, and the acetylator phenotype affects their handling. The acetylation reaction is also relevant to carcinogen activation, because N-acetylation and O-acetylation of aromatic amines can produce reactive species that damage DNA. The unifying principle is that the acetyl group is a transferable chemical unit, and any nucleophilic site on a drug or its metabolite is a potential acceptor.

How Acetylation Is Measured

Acetylation is detected and quantified with a standard toolkit. The choice of method depends on whether you want to know that a modification exists, where it is, or how much of it there is.

Western blot with pan-acetyllysine or site-specific antibodies. Pan-acetyllysine antibodies recognize N-epsilon-acetyllysine on many proteins at once. Site-specific antibodies such as anti-H3K9ac recognize one mark on one residue.
Chromatin immunoprecipitation followed by sequencing (ChIP-seq). This maps where a histone mark sits across the genome. It requires an antibody against the mark and enough cells to generate a library.
iCUT&Tag. An improved chromatin profiling method that requires as few as 500 nuclei, which makes it practical for scarce or metabolite-rich samples such as fruit tissue [6].
Mass spectrometry-based acetylome analysis. This identifies acetylated peptides and their exact sites after enrichment, and it is the main discovery tool for non-histone acetylation [12].
Recombinant enzyme assays. Purified acetyltransferases or deacetylases are incubated with substrate and cofactor, and activity is read by fluorometric, colorimetric, radiometric, fluorescence polarization, TR-FRET, AlphaScreen/AlphaLISA, or differential scanning fluorimetry methods [12].
Cell-based reporter systems. A reporter gene is placed under the control of a promoter whose acetylation status changes with treatment, giving a functional readout of acetylation-dependent transcription [12].

The workflow below shows the main decision path from a biological question to the appropriate acetylation assay.

flowchart TD
    A[Question about acetylation] --> B{Histone or non histone}
    B -->|Histone mark| C[Choose target mark]
    B -->|Non histone| D[Enrich acetylated peptides]
    C --> E[ChIP seq or iCUT and Tag]
    D --> F[Mass spectrometry acetylome]
    E --> G[Map peaks to promoters]
    F --> H[Identify sites and proteins]
    G --> I[Correlate with RNA seq]
    H --> I
    I --> J[Test writer or eraser enzyme]
    J --> K[Recombinant [activity assay](/knowledge/diagnostics/molecular/enzyme-activity-assay)]
    K --> L[Confirm with inhibitor or activator]

Common Mistakes and Limitations

A few errors trip up students and bench scientists repeatedly.

The first is assuming that acetylation always activates. It activates transcription when it occurs on histone tails at active promoters, but on non-histone proteins it can stabilize, destabilize, or change activity depending on the site. The Diap1 example shows a deacetylation event that stabilizes a protein, which is the opposite of the histone rule [8].

The second is confusing acetylation with methylation. Both can occur on lysine, and they can compete for the same residue, but they use different donors (acetyl-CoA versus S-adenosylmethionine), different enzymes, and different reader modules. Methylation does not neutralize charge, and its effect on transcription depends on how many methyl groups are added and which residue carries them.

The third is treating an acetyltransferase or deacetylase as if it had one substrate. These enzymes act on hundreds of targets, and a drug or genetic manipulation that inhibits one will affect many pathways. HDAC inhibitors used in research change the acetylation of histones and non-histone proteins at the same time, so a phenotype cannot be attributed to chromatin alone without controls.

The fourth is forgetting that acetylation is reversible and dynamic. A single Western blot is a snapshot. Acetylation levels depend on the balance between writers and erasers, on acetyl-CoA availability, and on the activity of readers that protect marks from removal.

The fifth is overreading a correlation between a mark and gene expression. H3K9ac enrichment at a promoter suggests that the gene is or was active, but it does not prove causation. Causality requires perturbing the writer or eraser and measuring the transcriptional consequence, as was done for GhHAT11 in cotton and BpHST1 in birch [4][5].

A practical limitation is that antibodies vary in specificity. A pan-acetyllysine antibody may cross-react with other acyl modifications, and site-specific antibodies can be blocked by neighboring modifications. Validation with peptide competition or a knockout control is standard practice.

Finally, individual patient responses to drugs such as isoniazid depend on genotype, organ function, and co-medications, and they require professional evaluation. Nothing in this article substitutes for that assessment.

Quick Review

The acetyl group is CH3CO-. It is transferred from acetyl-CoA onto lysine nitrogen, forming N-epsilon-acetyllysine and removing a positive charge.
Histone lysine acetylation generally opens chromatin and promotes transcription. Deacetylation by HDACs generally compacts chromatin and represses it.
Writers add the mark, erasers remove it, and readers such as bromodomain proteins interpret it.
Non-histone acetylation regulates protein stability, localization, and activity across the DNA damage response, cytoskeleton, autophagy, and metabolism.
Acetylation crosstalks with methylation and phosphorylation, and it competes with other acyl modifications for the same lysines.
Drug acetylation matters clinically. NAT2 acetylates isoniazid with fast and slow acetylator phenotypes, and aspirin irreversibly acetylates COX to block prostaglandin synthesis.
Acetylation is measured by Western blot, ChIP-seq, iCUT&Tag, mass spectrometry, and recombinant enzyme assays.

Frequently Asked Questions

What is an acetylation group?

An acetylation group is the acetyl unit CH3CO- when it is attached to a target molecule. In proteins, it is usually bonded to the epsilon nitrogen of a lysine side chain, forming an amide that removes the lysine positive charge.

Does histone acetylation turn genes on or off?

Histone lysine acetylation generally turns genes on. The neutralized lysine loosens the histone tail from DNA, opening chromatin so transcription factors and RNA polymerase can access the promoter. Deacetylation reverses this and usually represses transcription.

What is the difference between a writer and an eraser in epigenetics?

A writer is an enzyme that adds a modification, such as a histone acetyltransferase adding an acetyl group. An eraser removes it, such as a histone deacetylase. Readers are proteins that bind the mark and recruit downstream machinery.

How does aspirin acetylate COX?

Aspirin transfers its acetyl group to a serine residue in the cyclooxygenase active site. The bond is covalent and irreversible, so the enzyme stays blocked. Platelets cannot make new COX, so the antiplatelet effect lasts for the platelet lifespan.

Why do people respond differently to isoniazid?

Isoniazid is acetylated by NAT2, and common polymorphisms in the NAT2 gene produce fast and slow acetylator phenotypes. Slow acetylators clear the drug more slowly and have higher exposure, which affects the risk of certain side effects.

Can acetylation be reversed?

Yes. Acetylation is a reversible post-translational modification. Deacetylases remove the acetyl group, and the balance between acetyltransferases and deacetylases sets the steady-state level of the mark on any given protein.